ANIK 8-K 2026-07-29

Anika Therapeutics, Inc. (ANIK) 8-K dated 2026-07-29 — accession 0001171843-26-004977. This URL is the filing, not the ANIK hub.

Anika Therapeutics, Inc. (ANIK) is a drug manufacturers - specialty & generic company listed on US.

Anika Therapeutics, Inc. filed a 8-K on 2026-07-29. Accession 0001171843-26-004977.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ANIK revenue for 2025-12-31 was $112.8M. Net income was -$10.9M. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. ANIK currently screens at market cap $161.3M.

Not investment advice. The ANIK SEC hub lists recent forms. The stock page is the research view.